Healthcare provider profile · identity verified

Joseph Fuqua

Internal Medicine · BIRMINGHAM, AL · NPI 1821316043

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	368	118
Amlodipine Besylate	Amlodipine Besylate	341	111
Levothyroxine Sodium	Levothyroxine Sodium	306	85
Rosuvastatin Calcium	Rosuvastatin Calcium	265	85
Pantoprazole Sodium	Pantoprazole Sodium	242	74
Losartan Potassium	Losartan Potassium	209	66
Lisinopril	Lisinopril	196	60
Omeprazole	Omeprazole	182	61
Trazodone Hcl	Trazodone Hcl	179	48
Ozempic	Semaglutide	152	25
Gabapentin	Gabapentin	147	47
Metformin Hcl Er	Metformin Hcl	137	50
Tamsulosin Hcl	Tamsulosin Hcl	130	40
Metformin Hcl	Metformin Hcl	129	39
Hydrochlorothiazide	Hydrochlorothiazide	125	44
Carvedilol	Carvedilol	122	42
Metoprolol Succinate	Metoprolol Succinate	122	42
Escitalopram Oxalate	Escitalopram Oxalate	108	32
Sertraline Hcl	Sertraline Hcl	94	27
Meloxicam	Meloxicam	91	33
Montelukast Sodium	Montelukast Sodium	90	25
Albuterol Sulfate Hfa	Albuterol Sulfate	85	30
Simvastatin	Simvastatin	84	24
Eliquis	Apixaban	82	17
Tramadol Hcl	Tramadol Hcl	82	16
Pravastatin Sodium	Pravastatin Sodium	81	27
Furosemide	Furosemide	79	27
Famotidine	Famotidine	76	28
Fluticasone Propionate	Fluticasone Propionate	76	32
Duloxetine Hcl	Duloxetine Hcl	73	19
Mounjaro	Tirzepatide	73	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	21
Metoprolol Tartrate	Metoprolol Tartrate	67	23
Glipizide Er	Glipizide	65	21
Tizanidine Hcl	Tizanidine Hcl	65	17
Chlorthalidone	Chlorthalidone	61	19
Jardiance	Empagliflozin	59	15
Esomeprazole Magnesium	Esomeprazole Magnesium	56	17
Bupropion Xl	Bupropion Hcl	55	18
Clopidogrel	Clopidogrel Bisulfate	53	13
Potassium Chloride	Potassium Chloride	53	18
Buspirone Hcl	Buspirone Hcl	52	20
Azithromycin	Azithromycin	51	50
Olmesartan Medoxomil	Olmesartan Medoxomil	51	15
Clonazepam	Clonazepam	50	suppressed
Ezetimibe	Ezetimibe	47	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	13
Celecoxib	Celecoxib	44	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	42	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	16
Spironolactone	Spironolactone	42	14
Pregabalin	Pregabalin	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	40	12
Allopurinol	Allopurinol	39	14
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Atenolol	Atenolol	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	11
Alendronate Sodium	Alendronate Sodium	34	12
Januvia	Sitagliptin Phosphate	34	suppressed
Atovaquone-Proguanil Hcl	Atovaquone/Proguanil Hcl	33	31
Ondansetron Hcl	Ondansetron Hcl	33	13
Amitriptyline Hcl	Amitriptyline Hcl	32	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Lorazepam	Lorazepam	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Finasteride	Finasteride	30	suppressed
Methocarbamol	Methocarbamol	29	15
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Rizatriptan	Rizatriptan Benzoate	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Ondansetron Odt	Ondansetron	23	15
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Warfarin Sodium	Warfarin Sodium	23	suppressed
Diazepam	Diazepam	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Naproxen	Naproxen	18	suppressed
Primidone	Primidone	18	suppressed
Baclofen	Baclofen	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Carbamazepine Er	Carbamazepine	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Etodolac	Etodolac	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Colchicine	Colchicine	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Fluconazole	Fluconazole	13	12
Lovastatin	Lovastatin	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Xanax	Alprazolam	13	suppressed
Cholestyramine Light	Cholestyramine	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Levetiracetam	Levetiracetam	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error